CPSA Shanghai 2014

The New Era of Personalized Medicine:
Innovative Approaches for Drug Discovery and Development

Program Chair
Jeff Zhang	Novartis	China

Patrick Bennett	PPD	USA
Chad Briscoe	PRA International	USA
Cheng Chang	Pfizer	USA
Liangfu Chen	GlaxoSmithKline	USA
Weiqing Chen	ChemPartner	China
Ziqiang "Zack" Cheng	AstraZeneca	China
Stephen Clarke	GlaxoSmithKline	Europe
Richard Connell	Pfizer	China
Kelly Dong	GlaxoSmithKline	China
Alicia Du	ChemPartner	China
Todd Gillespie	Eli Lilly and Company	USA
Cornelis Hop	Genentech	USA
Chao-Pin Lee	GlaxoSmithKline	China
Chuan Li	Shanghai Institute of Materia Medica	China
Fred Li	Hua Medicine	China
Jing Lin	Sunovion Pharmaceuticals	USA
Mingqiu Lu	Roche	China
Tim Olah	Bristol-Myers Squibb	USA
Joseph Polli	GlaxoSmithKline	USA
Haojing Rong	Pfizer	USA
Yang Sai	Hutchison MediPharma	China
Jun Shi	Roche	China
Young Shin	Chungnam National University	China
Daniel Tang	ICON	China
Philip Timmerman	Janssen Pharmaceuticals	Europe
Gary Valaskovic	New Objective	USA
Frances Wang	Roche	China
Naidong Weng	Janssen Pharmaceuticals	USA
Catherine CL Wong	National Center for Protein Science	China
John Yates	The Scripps Research Institute	USA
Hongshi Yu	WuXi AppTec	China
Kate Yu	Waters Corporation	USA
Jenny Zheng	Janssen Pharmaceuticals	China
Dafang Zhong	Shanghai Institute of Materia Medica	China
Shaolian Zhou	Novartis	China